COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Growth Factors and Hepatic Progenitor Cells in Acute Liver Failure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01312220
Recruitment Status : Unknown
Verified February 2011 by National Taiwan University Hospital.
Recruitment status was:  Recruiting
First Posted : March 10, 2011
Last Update Posted : March 10, 2011
Sponsor:
Information provided by:
National Taiwan University Hospital

Brief Summary:
To study the correlation of serological growth factors and the hepatic progenitor cells involved in liver regeneration of liver failure.

Condition or disease
the Focus of the Study is to Correlate the Growth Factors in Serum With the Progenitor Cells in Liver

Layout table for study information
Study Type : Observational
Estimated Enrollment : 10 participants
Observational Model: Cohort
Official Title: Relationship of Serological Growth Factors and Hepatic Progenitor Cells in Acute Liver Failure
Study Start Date : February 2011
Estimated Study Completion Date : February 2013



Biospecimen Retention:   Samples With DNA
Serum Liver piece


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
acute liver failure who received liver transplantation
Criteria

Inclusion Criteria:

Acute liver failure Received iver transplantation

Exclusion Criteria:

Pregnancy Sepsis Heart failure


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01312220


Contacts
Layout table for location contacts
Contact: CM Ho, MD +88623123456 ext 65914 miningho@ntu.edu.tw

Locations
Layout table for location information
Taiwan
NTUH Recruiting
Taipei, Taiwan, 100
Contact: CM Ho, MD    +88623123456 ext 65914    miningho@ntu.edu.tw   
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Layout table for investigator information
Principal Investigator: CM Ho, MD National Taiwan University Hospital
Layout table for additonal information
Responsible Party: CM Ho, NTUH
ClinicalTrials.gov Identifier: NCT01312220    
Other Study ID Numbers: 201101061RC
First Posted: March 10, 2011    Key Record Dates
Last Update Posted: March 10, 2011
Last Verified: February 2011
Additional relevant MeSH terms:
Layout table for MeSH terms
Liver Failure
Liver Failure, Acute
Hepatic Insufficiency
Liver Diseases
Digestive System Diseases